Fox Chase Cancer Center Receives Press Ganey’s 2020 Guardian of Excellence Award

PHILADELPHIA (October 6, 2020)—Press Ganey has recognized Fox Chase Cancer Center with its 2020 Guardian of Excellence Award for providing outstanding clinical performance for patients in its outpatient clinics.

“I would like to commend the Fox Chase Cancer Center Medical Group for its exceptional performance in the CGCAHPS survey, which led to this honor,” said Richard I. Fisher, MD, president and CEO of Fox Chase. “This kind of recognition is meaningful because it originates from feedback provided by our own patients.”

Performance data comes the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) survey, which is administered by the U.S. Department of Health and Human Services through its Agency for Healthcare Research and Quality.

The award honors organizations who continually perform in the top 5% for patient experience, engagement, or clinical quality performance throughout each quarter of the award year. At least 75% of the entire practice must meet the criteria in the national facilities database.

CGCAHPS is a standardized tool that measures patients’ perception of care provided by physicians in an office setting. It is a sister survey to the more well-known HCAHPS survey, which focuses on inpatient hospital care. The current version of the CGCAHPS survey includes 31 core questions for patients and is viewed as the industry benchmark for patient assessment of healthcare providers.

Press Ganey is an independent market leader in helping healthcare institutions measure patient satisfaction and better understand the patient experience.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427